Health ProductsType I recall

Philips Respironics BiPAP and Humidifiers

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - General hospital and personal use
Product: Philips Respironics BiPAP and Humidifiers
Issue: Medical devices - Performance
What to do: Contact the manufacturer if you require additional information.
Audience: Healthcare
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberAffected productsModel or catalog number
All lots.BiPAP A40 Pro, CA W/ Heated Tube Humidifier, CACAX3100T12
All lots.BiPAP A40 Pro, CaCAX3100S12
All lots.BiPAP A30 System1111147
All lots.BiPAP A30 System - Ventilator & System One A-Series Heated Humidifier1111148
All lots.BiPAP A40, Canada1109596
1111173
1111174

Issue

The affected products feature a ventilator inoperative alarm, which occurs when the ventilator detects an internal error or a condition that may affect therapy. this may manifest in the following ways:

The device may reboot intermittently for 5-10 seconds (stops providing therapy, screen goes blank during the reboot, and there is a single audible alert), restarting therapy, and returning to delivering therapy with same patient settings.

or

The device may reboot intermittently for 5-10 seconds (stops providing therapy, screen goes blank during the reboot, and there is a single audible alert), restarting therapy, and returning to delivering therapy but with factory default settings.

or

When there are three (3) reboots within a 24-hour period, the device will enter a ventilator inoperative state (therapy stopped, audible and visual alarms present).

or

The device may enter a ventilator inoperative state without a reboot preceding this condition.

Any of the above scenarios could result in interruption and/or loss of therapy which may lead to hypoventilation, mild to severe hypoxemia, hypercarbia, respiratory failure/insufficiency, or potentially death in the most vulnerable patients.

Recall start date: March 19, 2024

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime